First Time Loading...

ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 277 JPY -1.09% Market Closed
Updated: May 18, 2024

Balance Sheet

Balance Sheet Decomposition
ASKA Pharmaceutical Holdings Co Ltd

Current Assets 56.1B
Cash & Short-Term Investments 17.2B
Receivables 15.6B
Other Current Assets 23.3B
Non-Current Assets 34.6B
Long-Term Investments 15.7B
PP&E 11.3B
Intangibles 2.9B
Other Non-Current Assets 4.8B
Current Liabilities 24B
Accounts Payable 7.4B
Accrued Liabilities 1.2B
Short-Term Debt 300m
Other Current Liabilities 15.1B
Non-Current Liabilities 4.8B
Long-Term Debt 4.5B
Other Non-Current Liabilities 342m

Balance Sheet
ASKA Pharmaceutical Holdings Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
5 462
14 761
10 221
10 982
7 294
10 514
12 103
14 505
13 738
Cash Equivalents
5 462
14 761
10 221
10 982
7 294
10 514
12 103
14 505
13 738
Short-Term Investments
0
0
0
0
0
0
5 000
3 400
3 500
Total Receivables
8 555
9 485
10 400
11 022
13 792
13 153
14 482
15 217
15 579
Accounts Receivables
8 555
9 485
10 400
11 022
13 792
13 153
14 482
15 217
15 579
Other Receivables
0
0
0
0
0
0
0
0
0
Inventory
11 125
10 683
11 868
14 005
14 042
14 372
15 060
17 687
20 402
Other Current Assets
1 736
2 130
2 329
1 820
2 198
1 893
2 912
2 950
2 924
Total Current Assets
26 878
37 059
34 818
37 829
37 326
39 932
49 557
53 759
56 143
PP&E Net
13 801
12 829
12 129
13 573
13 539
12 675
10 936
10 796
11 263
PP&E Gross
13 801
12 829
12 129
13 573
13 539
12 675
10 936
10 796
11 263
Accumulated Depreciation
28 323
29 284
30 073
30 721
31 792
32 504
24 244
25 042
23 344
Intangible Assets
368
3 491
1 140
9 598
9 368
11 893
817
792
767
Goodwill
2 928
0
2 219
5 734
4 216
0
5 366
3 673
2 110
Long-Term Investments
8 985
8 714
11 747
11 052
9 794
12 503
12 223
14 385
15 654
Other Long-Term Assets
4 518
4 033
4 182
4 408
5 996
5 579
4 398
3 733
4 808
Other Assets
2 928
0
2 219
5 734
4 216
0
5 366
3 673
2 110
Total Assets
57 478
N/A
66 126
+15%
66 235
+0%
82 194
+24%
80 239
-2%
82 582
+3%
83 297
+1%
87 138
+5%
90 745
+4%
Liabilities
Accounts Payable
3 784
5 309
5 217
7 107
6 040
6 455
6 841
5 860
7 355
Accrued Liabilities
958
1 069
1 086
895
997
1 151
1 188
1 166
1 225
Short-Term Debt
1 650
450
450
450
450
350
300
300
300
Current Portion of Long-Term Debt
808
750
750
3 048
2 298
2 298
1 423
3 138
4 680
Other Current Liabilities
3 792
8 675
6 711
6 502
7 342
6 483
6 259
7 186
10 408
Total Current Liabilities
10 992
16 253
14 214
18 002
17 127
16 737
16 011
17 650
23 968
Long-Term Debt
3 250
2 500
1 750
12 970
13 671
13 747
12 323
9 185
4 505
Other Liabilities
7 275
7 862
7 712
7 766
7 868
7 588
6 071
5 770
342
Total Liabilities
21 517
N/A
26 615
+24%
23 676
-11%
38 738
+64%
38 666
0%
38 072
-2%
34 405
-10%
32 605
-5%
28 815
-12%
Equity
Common Stock
1 197
1 197
1 197
1 197
1 197
1 197
1 197
1 197
1 197
Retained Earnings
34 759
37 312
39 280
40 630
39 560
41 790
45 833
49 619
56 372
Additional Paid In Capital
851
851
851
913
928
928
1 867
1 847
1 848
Unrealized Security Profit/Loss
0
2 726
3 657
3 130
2 293
2 824
3 231
4 590
4 790
Treasury Stock
0
2 396
2 278
2 281
2 191
2 139
3 479
3 350
3 287
Other Equity
420
179
148
133
214
90
243
630
1 010
Total Equity
35 961
N/A
39 511
+10%
42 559
+8%
43 456
+2%
41 573
-4%
44 510
+7%
48 892
+10%
54 533
+12%
61 930
+14%
Total Liabilities & Equity
57 478
N/A
66 126
+15%
66 235
+0%
82 194
+24%
80 239
-2%
82 582
+3%
83 297
+1%
87 138
+5%
90 745
+4%
Shares Outstanding
Common Shares Outstanding
28
28
28
28
28
28
28
28
28

See Also

Discover More